Fulvio Braido,1 Federico Lavorini,2 Francesco Blasi,3 Ilaria Baiardini,1,* Giorgio Walter Canonica1,* 1Respiratory and Allergy Diseases Clinic, Department of Internal Medicine, University of Genoa, IRCCS AOU San Martino-IST, Genoa, 2Department of Experimental and Clinical Medicine, Careggi University Hospital, Florence, 3Department of Pathophysiology and Transplantation, Università degli Studi di Milano, IRCCS Fondazione Ca’ Granda, Ospedale Maggiore Policlinico, Milan, Italy *These authors contributed equally to this work Abstract: Inhaled therapy is key to the management of chronic obstructive pulmonary disease (COPD). New drugs and inhalers have recently been launched or will soon become available, and the expiry of ...
Chronic obstructive pulmonary disease (COPD) is an inflammatory lung disease characterised by persis...
Chloe I Bloom,1 SL Elkin,2 JK Quint1 1National Heart and Lung Institute, Imperial College London, L...
Introduction: Inhaled corticosteroids (ICS) (in fixed combinations with long-acting β2-agonists [LAB...
Inhaled therapy is key to the management of chronic obstructive pulmonary disease (COPD). New drugs ...
Inhaled therapy is key to the management of chronic obstructive pulmonary disease ( COPD). New drugs...
Prescription cost-containment measures are increasing in many European countries and, as more inhale...
Pressure on healthcare budgets is increasing, while at the same time patent protection for many bran...
Pressure on healthcare budgets is increasing, while at the same time patent protection for many bran...
Alessandro Roggeri,1 Claudio Micheletto,2 Daniela Paola Roggeri1 1ProCure Solutions, Nembro, Bergam...
Josep Darbà,1 Gabriela Ramírez,2 Antoni Sicras,3 Pablo Francoli,4 Saku Torvinen,5 Rain...
Chronic obstructive pulmonary disease (COPD) is a major cause of mortality worldwide, whose burden i...
Chronic obstructive pulmonary disease (COPD) is a condition with a relevant clinical and economic bu...
Antonio Molino,1,* Giovanna Calabrese,1,* Mauro Maniscalco2 1Division of Pneumology, Department of ...
Introduction: The aim was to investigate how the pattern of pharmacological treatment in Swedish pat...
Timothy E Albertson,1–3 Richart Harper,1,2 Susan Murin,1,2 Christian Sandrock1 1Department of...
Chronic obstructive pulmonary disease (COPD) is an inflammatory lung disease characterised by persis...
Chloe I Bloom,1 SL Elkin,2 JK Quint1 1National Heart and Lung Institute, Imperial College London, L...
Introduction: Inhaled corticosteroids (ICS) (in fixed combinations with long-acting β2-agonists [LAB...
Inhaled therapy is key to the management of chronic obstructive pulmonary disease (COPD). New drugs ...
Inhaled therapy is key to the management of chronic obstructive pulmonary disease ( COPD). New drugs...
Prescription cost-containment measures are increasing in many European countries and, as more inhale...
Pressure on healthcare budgets is increasing, while at the same time patent protection for many bran...
Pressure on healthcare budgets is increasing, while at the same time patent protection for many bran...
Alessandro Roggeri,1 Claudio Micheletto,2 Daniela Paola Roggeri1 1ProCure Solutions, Nembro, Bergam...
Josep Darbà,1 Gabriela Ramírez,2 Antoni Sicras,3 Pablo Francoli,4 Saku Torvinen,5 Rain...
Chronic obstructive pulmonary disease (COPD) is a major cause of mortality worldwide, whose burden i...
Chronic obstructive pulmonary disease (COPD) is a condition with a relevant clinical and economic bu...
Antonio Molino,1,* Giovanna Calabrese,1,* Mauro Maniscalco2 1Division of Pneumology, Department of ...
Introduction: The aim was to investigate how the pattern of pharmacological treatment in Swedish pat...
Timothy E Albertson,1–3 Richart Harper,1,2 Susan Murin,1,2 Christian Sandrock1 1Department of...
Chronic obstructive pulmonary disease (COPD) is an inflammatory lung disease characterised by persis...
Chloe I Bloom,1 SL Elkin,2 JK Quint1 1National Heart and Lung Institute, Imperial College London, L...
Introduction: Inhaled corticosteroids (ICS) (in fixed combinations with long-acting β2-agonists [LAB...